Sahlgrenska University Hospital advances among the world’s best hospitals
Sahlgrenska University Hospital’s focused efforts to improve care and invest in clinical research and innovation, always with the patient at the centre, is gaining international recognition. In the international magazine Newsweek’s recently published ranking of the world’s best hospitals, Sahlgrenska University Hospital is ranked 66th, up from 69th last year.
“This year’s ranking shows that our work to become one of Europe’s leading university hospitals by 2032, with staff, patients and ways of working in focus, is being recognised internationally. Over the past year, we have intensified our international collaborations while increasing our capacity. We have almost halved the number of patients waiting more than a year for surgery, while bed occupancy rates have fallen,” says Boubou Hallberg, Chief Executive Officer.
In recent years, Sahlgrenska University Hospital has advanced in Newsweek’s ranking of the world’s best hospitals. Over the past four years, the hospital has climbed from 45th to 36th place in Europe and from 84th to 66th globally – out of more than 2,500 hospitals assessed. Newsweek’s ranking is based on a range of parameters and a comprehensive evaluation process, including a survey of thousands of medical experts (doctors, hospital managers and healthcare professionals), quality indicators and how hospitals work with so-called PROMs (Patient Reported Outcome Measures). PROMs show how patients themselves experience their illness and health after treatment or other interventions and are measured using standardised questionnaires.
“We are particularly proud that Sahlgrenska University Hospital receives the highest rating in Newsweek’s ranking for our work with PROMs. Only nine of the top-ranked hospitals in the world receive the top score, and Sahlgrenska University Hospital is one of them,” says Boubou Hallberg.
In 2025, the hospital has increased collaboration within the life sciences sector through strategic partnerships, for example with the National University Health System (NUHS) in Singapore, Oslo University Hospital and several leading industry partners, such as AstraZeneca.
The specialised care provided at Sahlgrenska University Hospital is also gaining international attention. Last year, for example, doctors from Memorial Sloan Kettering Cancer Center in New York, one of the world’s leading cancer hospitals, visited Gothenburg to learn more about the ILP method (isolated limb perfusion), an advanced treatment for tumours in the arms and legs. Sahlgrenska University Hospital is the only provider of this treatment in Sweden and is internationally regarded as one of the world’s leading centres, both in clinical practice and in research in this field.